BFI Finance Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp785 (market cap 12.03T, 12.2M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 73.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (12.2M versus 214.9K). Which is the better fit depends on your goals.
| BFIN | OBAT | |
|---|---|---|
Market Cap | 12.03T | 164.65B |
Volume | 12.2M | 214.9K |
Lot | 122K | 2.15K |
Turnover | 9.55B | 51.97M |
Average Price | 782.93 | 241.85 |
Value | 9.55B | 51.97M |
Indicative Equilibrium Price | 785 | 240 |
Indicative Equilibrium Volume | 5.52K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →